These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1874750)

  • 1. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies.
    Paul S; Mei S; Mody B; Eklund SH; Beach CM; Massey RJ; Hamel F
    J Biol Chem; 1991 Aug; 266(24):16128-34. PubMed ID: 1874750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site specificity of a catalytic vasoactive intestinal peptide antibody. An inhibitory vasoactive intestinal peptide subsequence distant from the scissile peptide bond.
    Paul S; Volle DJ; Powell MJ; Massey RJ
    J Biol Chem; 1990 Jul; 265(20):11910-3. PubMed ID: 2365706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.
    Paul S; Volle DJ; Beach CM; Johnson DR; Powell MJ; Massey RJ
    Science; 1989 Jun; 244(4909):1158-62. PubMed ID: 2727702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide hydrolysis by antibody light chains.
    Mei S; Mody B; Eklund SH; Paul S
    J Biol Chem; 1991 Aug; 266(24):15571-4. PubMed ID: 1908455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.
    Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):241-53; discussion 253-5. PubMed ID: 7944341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
    Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
    J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S; Volle DJ; Mei S
    J Immunol; 1990 Aug; 145(4):1196-9. PubMed ID: 2380555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidolytic monoclonal antibody elicited by a neuropeptide.
    Paul S; Sun M; Mody R; Tewary HK; Stemmer P; Massey RJ; Gianferrara T; Mehrotra S; Dreyer T; Meldal M
    J Biol Chem; 1992 Jul; 267(19):13142-5. PubMed ID: 1377678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of autoantibodies to vasoactive intestinal peptide in asthma.
    Paul S; Said SI; Thompson AB; Volle DJ; Agrawal DK; Foda H; de la Rocha S
    J Neuroimmunol; 1989 Jul; 23(2):133-42. PubMed ID: 2542371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a vasoactive intestinal polypeptide-degrading endoprotease from porcine antral mucosal membranes.
    Jeohn GH; Takahashi K
    J Biol Chem; 1995 Apr; 270(14):7809-15. PubMed ID: 7713870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    J Biol Chem; 1994 Dec; 269(51):32389-93. PubMed ID: 7798238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new effector mechanism for antibodies: catalytic cleavage of peptide bonds.
    Paul S
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():283-6. PubMed ID: 2639756
    [No Abstract]   [Full Text] [Related]  

  • 16. VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.
    Bangale Y; Karle S; Planque S; Zhou YX; Taguchi H; Nishiyama Y; Li L; Kalaga R; Paul S
    FASEB J; 2003 Apr; 17(6):628-35. PubMed ID: 12665475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of radiolabeled VIP binding and hydrolysis by antibodies.
    Huang H; Paul S
    Methods Mol Biol; 1995; 51():409-15. PubMed ID: 7581713
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.
    Tyutyulkova S; Gao QS; Thompson A; Rennard S; Paul S
    Biochim Biophys Acta; 1996 Aug; 1316(3):217-23. PubMed ID: 8781541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide: role of calmodulin and catalytic antibodies.
    Bolin DR
    Neurochem Int; 1993 Sep; 23(3):221-7. PubMed ID: 8220168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic hydrolysis of VIP in pregnant women with asthma.
    Olopade CO; Yu J; Abubaker J; Mensah E; Paul S
    J Asthma; 2006 Aug; 43(6):429-32. PubMed ID: 16952860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.